세계의 응고 검사 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Coagulation Testing Market is presumed to reach the market size of nearly USD 5.23 Billion by 2032 from USD 2.82 Billion in 2023 with a CAGR of 7.11% under the study period 2024-2034.

Coagulation testing is a diagnostic process assessing the blood's clot ability. It includes various laboratory tests that measure the clotting factors, platelet function, and overall coagulation cascade. These tests help diagnose and monitor conditions such as bleeding disorders, thrombosis, and liver disease. Common tests include prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalized ratio (INR), and thrombin time (TT). Results from these tests provide valuable information to healthcare providers for managing anticoagulant therapy, evaluating bleeding risks before surgery, and diagnosing coagulation disorders, contributing to optimal patient care and treatment outcomes.

MARKET DYNAMICS

The increasing prevalence of coagulation disorders such as hemophilia, thrombophilia, and von Willebrand disease, coupled with the spurring incidence of cardiovascular diseases, diabetes, and cancer, is driving demand for coagulation testing as a critical component of disease diagnosis, monitoring, and management. As healthcare providers strive to improve patient care & outcomes, coagulation testing is crucial in assessing bleeding and clotting disorders, guiding treatment decisions, and preventing complications such as thrombosis and hemorrhage. Moreover, the future of healthcare looks promising with technological advancements, including point-of-care (POC) devices, laboratory-based analyzers, and molecular assays, that are expanding access to accurate and timely testing solutions for healthcare facilities, clinics, and laboratories worldwide.

Furthermore, the increasing adoption of personalized medicine approaches and targeted therapies drives demand for coagulation testing assays to provide rapid and precise results to guide individualized treatment strategies, driving market growth. Moreover, the growing emphasis on preventive healthcare, wellness screenings, and early intervention strategies is driving the integration of these tests into routine health assessments and wellness programs, driving market expansion. However, advancements in alternative diagnostic methods and changes in healthcare regulations may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Coagulation Testing. The growth and trends of Coagulation Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Coagulation Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Instruments
• Consumables

By Test Type

• Prothrombin Time (PT)
• Activated Partial Thromboplastin Clotting Time (APTT)
• Thrombin Time (TT)
• Activated Clotting Time (ACT)
• Others

By End-user

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Coagulation Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Coagulation Testing market include F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, Sysmex Corporation, Universal Biosensors Inc., HemoSonics LLC, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Horiba Ltd., Agappe Diagnostics Ltd., Medtronic, Helena Laboratories Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. COAGULATION TESTING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Test Type
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product Type
• 5.4. Instruments Historic and Forecast Sales By Regions
• 5.5. Consumables Historic and Forecast Sales By Regions

6. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY TEST TYPE

• 6.1. Overview By Test Type
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Test Type
• 6.4. Prothrombin Time (PT) Historic and Forecast Sales By Regions
• 6.5. Activated Partial Thromboplastin Clotting Time (APTT) Historic and Forecast Sales By Regions
• 6.6. Thrombin Time (TT) Historic and Forecast Sales By Regions
• 6.7. Activated Clotting Time (ACT) Historic and Forecast Sales By Regions
• 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-user
• 7.2. Historical and Forecast Data
• 7.3. Analysis By End-user
• 7.4. Hospitals and Clinics Historic and Forecast Sales By Regions
• 7.5. Diagnostic Laboratories Historic and Forecast Sales By Regions
• 7.6. Home Care Settings Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE COAGULATION TESTING COMPANIES

• 9.1. Coagulation Testing Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF COAGULATION TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. F. Hoffmann-La Roche Ltd.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Abbott
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Siemens Healthineers
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Sysmex Corporation
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Universal Biosensors Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. HemoSonics LLC
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Thermo Fisher Scientific Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Randox Laboratories Ltd.
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Horiba Ltd.
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Agappe Diagnostics Ltd.
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Medtronic
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. Helena Laboratories Inc
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies